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ABSTRACT: Ten healthy controls, 9 Rheumatoid Arthritis patients and 5 cancer patients were 
studied for T and B cells in peripheral circulation.  T cell count in cancer patients showed a 
slight enhancement after receiving Ayurvedic Treatment; but the B cell count remained the same.  
In Rheumatoid Arthritis patients no significant change was noticed either in T cell or cell count. 
 
INTRODUCTION 
 
The abundance of literature in Ayurvedic 
system of medicine affords ample scope for 
research.  Cancer may be a manifestation of 
the break down of immune  surveillance.  
Some ayurvedic preparations are well 
known for their boosting of immune 
resistance in a man.  These drugs may be 
virtue of their immunostimulating action be 
potential candidates in cancer therapy.  This 
study is being undertaken to assess the effect 
of these drugs or combination of drugs on 
the immune status of patients.  
 
MATERIALS AND METHODS 
 
Patients attending Ayurveda Wing of Amala 
Hospital for treatment of cancer and 
rheumatoid arthritis were assessed for their 
immune status.  Cell mediated immunity in 
these patients, at start of the treatment and 
during treatment was studied by the 
following parameters:  (a) T and B 
lymphocyte count, (b) Delayed 
hypersensitivity test using PPD  skin  test.  
These patients were not received any prior 
treatment, 12 controls, 9 cases of rheumatoid 
arthritis and 5 cancer cases 4 of which were 
followed up were included in the present 
study.   
 
Enumeration of T and B Lymphocytes: In 
man T cells may be identified by their 
ability to form spontaneous  rosettes with 
sheep erythrocytes.  Sheep erythrocytes 
were collected in Alsevier’s solution and 
stored in fridge for less than one week.  The 
SRBCs were washed in 0.85% saline three 
times and made upto 1%.  Blood samples 
from patients collected in heparin, diluted to 
1:2 with sterile saline was carefully layered 
over Ficoll-Hypaque and centrifuged at 200 
rpm for twenty minutes.  The lymphocytes 
appearing as a white ring at the interface 
were carefully removed with a Pasteur 
pipette, washed with saline twice and count 
adjusted to 2 × 10
6 cells/ml.  Equal volumes 
of SRBC (1%) and purified lymphocytes 
were mixed and centrifuged at low speed; 
and incubated at 4
0 C over ice water bath for 
30 minutes. The pellet was resuspended 
gently and one drop of toludine blue (1%) 
was added.  T lymphocytes which have 
receptors for SRBC form spontaneous 
rosettes.  The total number of rosettes as 
well as free lymphocytes were counted and 
percentage calculated.   Pages 41-43 
 
 
 
TABLE-1 
T and B Cell count in patients before and after treatment 
 
 
Sl.No 
Normals 
Sl.No 
Rheumatoid arthritis patients 
Sl.No 
Cancer patients 
% T cells  % B cells  Before treatment  After treatment  Before treatment  After treatment 
% T cells  % B cells  % T cells  % B cells  % T cells  % B cells  % T cells  % B cells 
1.  77  32  1.  69.4  36  68  26.5  1.  63  23.5  71  26 
2.  70.4  37  2.  63.6  26  67  22.5  2.  59.4  25.8  64.7  24.8 
3.  73.6  30.3  3.  68  30  65.3  26.5  3.  71  22.3  66.3  24 
4.  71.7  17.3  4.  58  31  61.5  29  4.  62.5  27  64.6  22.3 
5.  76  25.8  5.  62  27  62.5  25.5  5.  67.5  26.5  --   -- 
6.  74.8  23.5  6.  72  19.5  68.5  22.3           
7.  73.2  32  7.  66  22.5  62  24           
8.  76.9  30  8.  73  21.5  68.5  27.5           
9.  77.2  19  9.  67.79  24.2  73  23.5           
10.  67  28                     
Mean  73.10 ±  28.93 ±    66.64 ±  26.40 ±  66.25 ±  25.50 ±    64.28 ±  25.02 ±  66.78 ±  24.26 ± 
± SD  3.57  5.35    4.80  5.20  3.78  2.32    2.98  2.02  4.56  1.50 
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Enumeration of B cells by E. A. C. rosette 
technique: 5 ml of 1% SRBC mixed with 5 
ml of 1/2000 diluted Amboceptor (Rabbit 
anti SRBC serum); incubated at 37
0 C for 
half an hour; and washed twice in RPMI 
medium.  Then 5 ml of 1:30 dilution (sub 
hemolytic dose) of fresh human serum was 
added as a complement source, and 
incubated at 37
0  C till haemolysis starts.   
Then the cells were washed twice and 5ml 
of media was added.  This is the EAC. To 
0.2 ml of EAC, 0.2 ml of lymphocyte 
preparation (2 × 10
6 cells/ml) was added and 
centrifuged at low speed for 5 minutes; and 
incubated at 4
0 C over ice water bath for half 
an hour.  The C’3  coated sheep red cells 
(EAC) when mixed with lymphocytes 
formed rosettes around the B lymphocytes 
which bear receptors for the activated C’3 
component of complement .  Then count 
was taken as in the case of T rosettes.  
 
Delayed Hypersensitivity test using PPD: 
On intradermal injection of the antigen to 
which the person has had a previous contact, 
an indurate erythematous swelling develops 
at the site of injection reaching a peak at 48-
72 hrs.  One unit PPD (0.01ml) was given 
intradermally on the volar aspect of forearm. 
The reading was taken 72 hrs later.   
Erythema and indurations of 10 × 10 mm or 
more was considered positive.  
 
Treatment schedule: In cancer patients 
drugs like Varandiquathem, Kanjanara 
gulgulu tablets, Rasa sinduram and Khadir 
arishtam have been administered orally in 
different combinations. For massage, 
Kottemchukkadi thailam and Pinda thailam 
were used and and in some cases treatment 
like navarakizhi have been given.  For 
arthritis patients drugs like Maharasnadi 
quatham and Yogaraja gulgula tablets have 
been administered orally.  Besides this, 
Sahacharadi thailam, Chinchadi thailam and 
Kottemchukkadi thailam have been 
prescribed for massage, and also treatment 
like Navarakizhi, patropodala Swedam and 
Kashayavasti were given.  
 
RESULTS 
 
10 normal healthy controls of both sexes 
have been studied.  The mean T cell and B 
cell count was found to be 73 ± 3.57 and 
28.93 ± 5.53 respectively. In rheumatoid 
arthritis patients, the percentage of T cell 
count was low at the start of treatment. After 
one month treatment, there was no 
considerable enhancement in their T cell 
count.  B cell count however, remained the 
same (Table 1). In cancer patients also the T 
cell count was low at the start of treatment. 
Levels estimated after one month of 
treatment showed slight increase in T cell 
count. There was no change in the B cell 
count (Table 1).   As the number of patients 
studied is small, significance could not be 
calculated.  Since the results of the treatment 
in patients are encouraging, further studies 
before the treatment, one month and three 
months after treatment are in progress.  
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